{"article": [{"url": "https://finance.yahoo.com/news/gilead-test-inhaled-version-remdesivir-131543812.html", "published": 1592814200.0, "headline": "Gilead to test inhaled version of remdesivir on COVID-19 patients in August", "body": "June 22 (Reuters) - Gilead Sciences Inc said on Monday that it plans to begin clinical trials of an inhaled version of its antiviral treatment remdesivir for COVID-19 patients in August.The drug is currently used intravenously and an inhaled formulation would be given through a nebulizer, which could potentially allow for easier administration outside hospitals, the company said in a statement. (https://bit.ly/3eqpEJ9) (Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)"}]}